Press releaseGlobe Newswire
Bright Minds Biosciences
DRUG · CANADIAN
$52.48−$0.21 (−0.40%)TodayMarket closed ·
Prev close $52.69
Latest news
- Press releaseGlobe Newswire
Vistagen Appoints Douglas J. Williamson to its Board of Directors
- Press releaseGlobe Newswire
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference
- News
'Trump To Sign Executive Order On Psychedelic Drug Used Abroad To Treat PTSD' - CBS News Exclusive
- Press releaseGlobe Newswire
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
- Press releaseGlobe Newswire
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock
- NewsAvi Kapoor
Crude Oil Down 2%; ISM Services PMI Surges In December
- NewsAvi Kapoor
Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- NewsAvi Kapoor
SanDisk To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday
- Press releaseGlobe Newswire
Bright Minds Biosciences Announces Launch of US$100 Million Public Offering
- NewsAvi Kapoor
Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday
- Press releaseGlobe Newswire
Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE)
- Press releaseGlobe Newswire
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)
- Press releaseGlobe Newswire
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH
- Press releaseGlobe Newswire
Bright Minds Biosciences to Present at Upcoming Conferences
- NewsVandana Singh
Large Patient Population Is Key Driver For Bright Minds' Growth
- Press releasePRNewswire
BRIGHT MINDS BIOSCIENCES ANNOUNCES AT-THE-MARKET OFFERING
- Press releaseGlobe Newswire
Bright Minds Biosciences Announces BMB‑201 Outperforms Sumatriptan in Validated Preclinical Vascular Headache Model
- News
Reported Earlier: 'The key to living longer could be tied to a surprising substance, study suggests'- Fox News
- News
'Colorado Moves to Allow Hallucinogen Ibogaine for Medical Use'- Bloomberg
- News
'Psychedelics Proponents Hope Trump Administration Will Foster A New Era' - STAT News
- Press releaseGlobe Newswire
Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025
- Press releaseGlobe Newswire
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101
- NewsVandana Singh
Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside
- Press releaseGlobe Newswire
Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study
- Press releaseGlobe Newswire
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research
- Press releaseGlobe Newswire
Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer
- Press releaseGlobe Newswire
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
- Press releaseGlobe Newswire
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement
- NewsChris Katje
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
- NewsAdam Eckert
What's Going On With Bright Minds Biosciences Stock?
- Press releaseGlobe Newswire
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data
- NewsAvi Kapoor
Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results
- NewsAvi Kapoor
Dow Falls Over 100 Points; Netflix Posts Upbeat Results
- News
Market-Moving News for October 18th
- NewsAvi Kapoor
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
- NewsAvi Kapoor
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
- NewsAvi Kapoor
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.